
|Articles|August 13, 2015
GSK: Legionnaires Disease Bacteria Causes Temporary Closedown of US Site
August 13, 2015.
Advertisement
The
GSK said the bacteria had been isolated after routine testing and that it is “working to rectify and restore operations as soon as possible”.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Marty Makary Out as FDA Commissioner: Report
3
The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff
4
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
5




